New Research Shows Liposomal Vitamin C Makes Skin 33% Firmer
News Feb 25, 2014
Abundance & Health has announced positive results of a 4 week clinical trial investigating the anti-aging skin firming properties of their lead product Altrient® C, the world’s first liposomal vitamin C gel.
The results of the trial demonstrated that participants taking Altrient C had significantly improved their skin elasticity over the 4-week period of the clinical trial, compared to those taking the placebo. Participants using Altrient C had improved skin firmness and elasticity by 32.7 percent over the same period.
After just 14 days, skin firmness and elasticity had already improved by 15.1 percent (over 1 percent a day on average). The trial tested the general skin firming properties of Altrient C, rather than just those parts of the body that lotions are commonly applied to. 100 percent of participants reported that they would switch to Altrient C in favour of their current anti-aging skincare product.
“Skin elasticity is a critical part in the visual aging process, and thousands of years of research has so far provided limited results. This research has demonstrated a clear link between the skin aging process and vitamin C via dietary supplements,” said Jonathan Orchard, Director, Abundance & Health. “However, up to 85 percent of the vitamin C contained in tablets and powders is destroyed in the digestive system. Altrient C's vitamin C is encased in a tiny bubble of protective fatty acids. This safeguards the vitamin through the harsh digestive system and the body’s absorption barriers, into the bloodstream, where it is transported through the body. This is a unique vitamin C delivery mechanism, ensuring maximum benefits. This research has shown that skin elasticity is considerably improved by this unique delivery system, ensuring that up to 98 percent of the vitamin C is absorbed straight into the bloodstream, reaching cells in the most effective way.”
The placebo-controlled trial was conducted by Aspen Clinical Research, the clinical and cosmetic industry researchers. The trial involved 60 participants with non-firm aging skin aged between 31 and 65+. 50 percent took 3 sachets of Altrient C a day for 4 weeks and 50 percent taking a placebo. Participants’ skin firmness and elasticity were measured at three points through the trial by Cutometer MPA 580, the Courage + Khazaka electronic GmbH elasticity measurement device.
After 4 weeks, 100 percent of participants who consumed Altrient C reported an overall improvement in the skin. 50 percent noticed greater hydration. 43 percent thought they looked younger. 33 percent thought their skin appeared more nourished. 100 percent would change their current anti-aging routine by not just adding Altrient C to their skin regime, but replacing all products they currently use with Altrient C.
Abundance & Health plan to run a second clinical trial for a longer period, in order to measure a peak in the skins improvement. The second trial will determine how long improvements in skin elasticity will continue, as well as how much additional improvement can be measured.
“Skin ageing is a complex process involving genetic, hormonal and environmental factors,” said Dr Sanjay Rajpara, dermatologist and cosmetic skin doctor. “Formation of free oxygen radicals is widely accepted as a pivotal mechanism leading to skin ageing. The production of free radicals increases with ageing. Vitamin C is an important part of the body’s anti oxidative defence mechanism. Although there are some studies showing this benefit in vitro, there are not many showing direct effects of vitamin C in humans. This is a good quality study showing improvement in skin elasticity in human skin over a period of 4 weeks. This product has a potential to become one of the first line products for anti-ageing.”
“At Aspen Clinical Research, a leading expert in claim substantiation, we test thousands of products every year. We conducted a 4-week trial based upon industry standard techniques to assess the skin firming capabilities of an ingested dietary supplement, Altrient C,” said Danny McCamlie, Lead Clinical Scientist and Principal Investigator at Aspen Clinical. “We found that Altrient C caused an increase in skin firmness and skin elasticity under Cutometery assessments. With an increase of 15.1 percent and 32.7 percent in skin firmness, following 2 and 4 weeks respectively, Altrient C achieved results that, in our experience, some topically applied creams fail to achieve following 8 weeks of use.”
There were some results in addition to skin firmness. Of those taking Altrient C suffering from colds and flu, 36 percent recovered in 1-2 days, and 64 percent recovered in 3 - 4 days. This was in comparison to the placebo respondents where 82 percent took 5 - 6 days to recover. In addition, all of the subjects consuming Altrient C also reported a significant increase in their energy levels.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE